301370 国科恒泰
已收盘 07-18 15:00:00
资讯
新帖
简况
国科恒泰7月17日现1笔大宗交易 成交金额1143.6万元
智能小浪 · 07-17 17:00
国科恒泰7月17日现1笔大宗交易 成交金额1143.6万元
7月17日国科恒泰现1143.6万元大宗交易
证券之星 · 07-17 16:36
7月17日国科恒泰现1143.6万元大宗交易
国科恒泰(301370)7月15日主力资金净卖出380.28万元
证券之星 · 07-16 09:14
国科恒泰(301370)7月15日主力资金净卖出380.28万元
国科恒泰7月15日现3笔大宗交易 成交金额824.4万元
智能小浪 · 07-15
国科恒泰7月15日现3笔大宗交易 成交金额824.4万元
7月15日国科恒泰现3笔折价10.02%的大宗交易 合计成交824.4万元
证券之星 · 07-15
7月15日国科恒泰现3笔折价10.02%的大宗交易 合计成交824.4万元
国科恒泰7月12日现10笔大宗交易 成交金额4442.46万元
智能小浪 · 07-12
国科恒泰7月12日现10笔大宗交易 成交金额4442.46万元
7月12日国科恒泰现10笔折价11.94%的大宗交易 合计成交4442.46万元
证券之星 · 07-12
7月12日国科恒泰现10笔折价11.94%的大宗交易 合计成交4442.46万元
国科恒泰(301370)2.53亿股限售股将于7月12日解禁,占总股本53.79%
证券之星 · 07-12
国科恒泰(301370)2.53亿股限售股将于7月12日解禁,占总股本53.79%
150.6亿元市值限售股今日解禁,中国东航、赛维时代、国科恒泰解禁市值居前
界面 · 07-12
150.6亿元市值限售股今日解禁,中国东航、赛维时代、国科恒泰解禁市值居前
国科恒泰(301370)7月10日主力资金净卖出616.91万元
证券之星 · 07-11
国科恒泰(301370)7月10日主力资金净卖出616.91万元
【机构调研记录】国联基金调研国科恒泰、联得装备
证券之星 · 07-10
【机构调研记录】国联基金调研国科恒泰、联得装备
【机构调研记录】华夏基金调研荣昌生物、国科恒泰
证券之星 · 07-10
【机构调研记录】华夏基金调研荣昌生物、国科恒泰
国科恒泰(301370.SZ)拟与丹江口创瑞共设合资公司 经营医疗器械生产及技术咨询服务
智通财经 · 07-03
国科恒泰(301370.SZ)拟与丹江口创瑞共设合资公司 经营医疗器械生产及技术咨询服务
国科恒泰:根据中登公司定期下发的股东名册显示,截至2024年6月7日,公司股东人数为16,674户
证券之星 · 06-17
国科恒泰:根据中登公司定期下发的股东名册显示,截至2024年6月7日,公司股东人数为16,674户
国科恒泰:根据中登公司定期下发的股东名册显示,截至2024年5月31日,公司股东人数为17,011户
证券之星 · 06-03
国科恒泰:根据中登公司定期下发的股东名册显示,截至2024年5月31日,公司股东人数为17,011户
国科恒泰(301370)5月20日股东户数1.69万户,较上期减少0.7%
证券之星 · 05-21
国科恒泰(301370)5月20日股东户数1.69万户,较上期减少0.7%
国科恒泰(301370)2024年一季报简析:净利润增4.82%
证券之星 · 04-26
国科恒泰(301370)2024年一季报简析:净利润增4.82%
图解国科恒泰一季报:第一季度单季净利润同比增4.82%
证券之星 · 04-25
图解国科恒泰一季报:第一季度单季净利润同比增4.82%
图解国科恒泰年报:第四季度单季净利润同比增105.79%
证券之星 · 04-25
图解国科恒泰年报:第四季度单季净利润同比增105.79%
国科恒泰最新公告:一季度净利润2760.55万元 同比增长4.82%
证券之星 · 04-24
国科恒泰最新公告:一季度净利润2760.55万元 同比增长4.82%
加载更多
公司概况
公司名称:
国科恒泰(北京)医疗科技股份有限公司
所属行业:
批发业
上市日期:
2023-07-12
主营业务:
国科恒泰(北京)医疗科技股份有限公司的主营业务是从事医疗器械的分销和直销业务,并在业务开展过程中提供仓储物流配送、流通渠道管理、流通过程信息管理以及医院SPD运营管理等专业服务;公司的主要产品是冠脉介入治疗材料、外周血管介入、骨科材料、消化介入材料、神经外科材料、口腔材料、仓储物流配送服务、渠道管理服务、信息管理服务、医院 SPD 运营服务。
发行价格:
13.39
{"stockData":{"symbol":"301370","market":"SZ","secType":"STK","nameCN":"国科恒泰","latestPrice":9.48,"timestamp":1721286207000,"preClose":9.69,"halted":0,"volume":5132236,"delay":0,"floatShares":324000000,"shares":471000000,"eps":0.3297,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.21,"latestTime":"07-18 15:00:00","open":9.64,"high":9.64,"low":9.38,"amount":48657800,"amplitude":0.0268,"askPrice":9.48,"askSize":57,"bidPrice":9.47,"bidSize":168,"shortable":0,"etf":0,"ttmEps":0.3297,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721352600000},"adr":0,"adjPreClose":9.69,"symbolType":"stock","openAndCloseTimeList":[[1721266200000,1721273400000],[1721278800000,1721286000000]],"highLimit":10.66,"lowLimit":8.72,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":470600000,"pbRate":1.85,"roa":"--","roe":"1.12%","epsLYR":0.36,"committee":0.212492,"marketValue":4461000000,"floatMarketCap":3069000000,"peRate":28.753413,"changeRate":-0.0217,"turnoverRate":0.0159,"status":1},"requestUrl":"/m/hq/s/301370","defaultTab":"news","newsList":[{"id":"2452138914","title":"国科恒泰7月17日现1笔大宗交易 成交金额1143.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452138914","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452138914?lang=zh_cn&edition=full","pubTime":"2024-07-17 17:00","pubTimestamp":1721206800,"startTime":"0","endTime":"0","summary":" 7月17日,国科恒泰收跌1.62%,收盘价为9.69元,发生1笔大宗交易,合计成交量120万股,成交金额1143.6万元。 第1笔成交价格为9.53元,成交120.00万股,成交金额1,143.60万元,溢价率为-1.65%,买方营业部为开源证券股份有限公司江苏分公司,卖方营业部为华泰证券股份有限公司无锡解放西路证券营业部。 进一步统计,近3个月内该股累计发生14笔大宗交易,合计成交金额为6410.46万元。该股近5个交易日累计下跌7.09%,主力资金合计净流出1725.37万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-07-17/doc-incemuhy9636959.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-07-17/doc-incemuhy9636959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2452180836","title":"7月17日国科恒泰现1143.6万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2452180836","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452180836?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:36","pubTimestamp":1721205375,"startTime":"0","endTime":"0","summary":"证券之星消息,7月17日国科恒泰发生大宗交易,交易数据如下:大宗交易成交价格9.53元,相对当日收盘价折价1.65%,成交120万股,成交金额1143.6万元,买方营业部为开源证券股份有限公司江苏分公司,卖方营业部为华泰证券股份有限公司无锡解放西路证券营业部。近三个月该股共发生14笔大宗交易,合计成交6.81万手,折价成交14笔。截至2024年7月17日收盘,国科恒泰报收于9.69元,下跌1.62%,换手率1.24%,成交量4.0万手,成交额3889.1万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700033544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2451986950","title":"国科恒泰(301370)7月15日主力资金净卖出380.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451986950","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451986950?lang=zh_cn&edition=full","pubTime":"2024-07-16 09:14","pubTimestamp":1721092473,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月15日收盘,国科恒泰报收于10.18元,下跌5.04%,换手率1.6%,成交量5.18万手,成交额5341.85万元。近5日资金流向一览见下表:国科恒泰融资融券信息显示,融资方面,当日融资买入233.75万元,融资偿还112.57万元,融资净买入121.19万元。国科恒泰主营业务:医疗器械的分销和直销业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600014314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370","BK0250"],"gpt_icon":0},{"id":"2451161436","title":"国科恒泰7月15日现3笔大宗交易 成交金额824.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451161436","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451161436?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:00","pubTimestamp":1721034000,"startTime":"0","endTime":"0","summary":" 7月15日,国科恒泰收跌5.04%,收盘价为10.18元,发生3笔大宗交易,合计成交量90万股,成交金额824.4万元。 进一步统计,近3个月内该股累计发生13笔大宗交易,合计成交金额为5266.86万元。该股近5个交易日累计下跌5.04%,主力资金合计净流出930.49万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-07-15/doc-incefhcc1666349.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-07-15/doc-incefhcc1666349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2451615377","title":"7月15日国科恒泰现3笔折价10.02%的大宗交易 合计成交824.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451615377","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451615377?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:40","pubTimestamp":1721032836,"startTime":"0","endTime":"0","summary":"证券之星消息,7月15日国科恒泰发生大宗交易,交易数据如下:近三个月该股共发生13笔大宗交易,合计成交5.61万手,折价成交13笔。该股在过去半年内已有共计2.53亿股限售解禁股上市,占公司总股本的53.79%。截至2024年7月15日收盘,国科恒泰报收于10.18元,下跌5.04%,换手率1.6%,成交量5.18万手,成交额5341.85万元。该股最近90天内无机构评级。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500020304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370","BK0250"],"gpt_icon":0},{"id":"2450305730","title":"国科恒泰7月12日现10笔大宗交易 成交金额4442.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450305730","media":"智能小浪","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450305730?lang=zh_cn&edition=full","pubTime":"2024-07-12 17:00","pubTimestamp":1720774800,"startTime":"0","endTime":"0","summary":" 7月12日,国科恒泰收跌1.65%,收盘价为10.72元,发生10笔大宗交易,合计成交量470.6万股,成交金额4442.46万元。 第10笔成交价格为9.44元,成交51.18万股,成交金额483.14万元,溢价率为-11.94%,买方营业部为国都证券股份有限公司江苏分公司,卖方营业部为华泰证券股份有限公司无锡解放西路证券营业部。 进一步统计,近3个月内该股累计发生10笔大宗交易,合计成交金额为4442.46万元。该股近5个交易日累计下跌4.20%,主力资金合计净流出753.14万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/ggzz/2024-07-12/doc-inccwkrt7769874.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-07-12/doc-inccwkrt7769874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2450213305","title":"7月12日国科恒泰现10笔折价11.94%的大宗交易 合计成交4442.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450213305","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450213305?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:50","pubTimestamp":1720774220,"startTime":"0","endTime":"0","summary":"证券之星消息,7月12日国科恒泰发生大宗交易,交易数据如下:近三个月该股共发生10笔大宗交易,合计成交4.71万手,折价成交10笔。该股在过去半年内已有共计2.53亿股限售解禁股上市,占公司总股本的53.79%。截至2024年7月12日收盘,国科恒泰报收于10.72元,下跌1.65%,换手率1.25%,成交量4.05万手,成交额4396.67万元。该股最近90天内无机构评级。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200032927.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2450343373","title":"国科恒泰(301370)2.53亿股限售股将于7月12日解禁,占总股本53.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450343373","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450343373?lang=zh_cn&edition=full","pubTime":"2024-07-12 08:02","pubTimestamp":1720742540,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,国科恒泰于7月12日将有2.53亿股限售股份解禁,为公司首发原股东限售股份,占公司总股本53.79%。最近一年内,该股累计解禁435.02万股,占总股本的0.92%。本次解禁后,公司还有1.47亿股限售股份,占总股本31.21%。国科恒泰主营业务:医疗器械的分销和直销业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200012242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370","BK0250"],"gpt_icon":0},{"id":"2450343925","title":"150.6亿元市值限售股今日解禁,中国东航、赛维时代、国科恒泰解禁市值居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2450343925","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450343925?lang=zh_cn&edition=full","pubTime":"2024-07-12 07:47","pubTimestamp":1720741632,"startTime":"0","endTime":"0","summary":"Wind数据显示,周五(7月12日),共有18家公司限售股解禁,合计解禁量为21.52亿股,按最新收盘价计算,合计解禁市值为150.6亿元。从解禁量来看,8家公司解禁股数超千万股。中国东航、ST天邦、国科恒泰解禁量居前,解禁股数分别为11.39亿股、3.83亿股、2.53亿股。从解禁市值来看,8家公司解禁股数超亿元。中国东航、赛维时代、国科恒泰解禁市值居前,解禁市值分别为44.76亿元、35.95亿元、27.59亿元。从解禁股数占总股本比例来看,4家公司解禁比例超10%。世茂能源、国科恒泰、赛维时代解禁比例居前,解禁比例分别为75.0%、53.79%、39.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712074712af91ebfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712074712af91ebfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0196","BK0209","BK0164","301381","301370","BK0188","600115","BK0010","BK0028","BK0020","BK0012","BK0183","BK0280","BK0250","BK0053","BK0006"],"gpt_icon":0},{"id":"2450879347","title":"国科恒泰(301370)7月10日主力资金净卖出616.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450879347","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450879347?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:19","pubTimestamp":1720660756,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月10日收盘,国科恒泰报收于10.43元,下跌5.44%,换手率7.1%,成交量5.01万手,成交额5343.08万元。近5日资金流向一览见下表:国科恒泰融资融券信息显示,融资方面,当日融资买入206.24万元,融资偿还508.2万元,融资净偿还301.96万元。国科恒泰主营业务:医疗器械的分销和直销业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100013559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2450000688","title":"【机构调研记录】国联基金调研国科恒泰、联得装备","url":"https://stock-news.laohu8.com/highlight/detail?id=2450000688","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450000688?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:01","pubTimestamp":1720569692,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月9日披露的机构调研信息,国联基金近期对2家上市公司进行了调研,相关名单如下:1)国科恒泰 个股亮点:公司的税务系统与国税系统对接,已经实现税企直联,针对自动开票、电子抵扣、税票验真等场景,向上下游合作伙伴提供服务;公司通过数据服务为医疗器械流通降本增效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370","300545","BK0251","BK0250","BK0152"],"gpt_icon":0},{"id":"2450500068","title":"【机构调研记录】华夏基金调研荣昌生物、国科恒泰","url":"https://stock-news.laohu8.com/highlight/detail?id=2450500068","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450500068?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:01","pubTimestamp":1720569683,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月9日披露的机构调研信息,华夏基金近期对2家上市公司进行了调研,相关名单如下:1)荣昌生物 个股亮点:H股:荣昌生物于2020-11-09上市2)国科恒泰 个股亮点:公司的税务系统与国税系统对接,已经实现税企直联,针对自动开票、电子抵扣、税票验真等场景,向上下游合作伙伴提供服务;公司通过数据服务为医疗器械流通降本增效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000012879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2148510915.USD","LU2328871848.SGD","09995","301370","LU1064130708.USD","BK1574","BK0239","LU1969619763.USD","BK0250","688331","BK1583","LU1064131003.USD","BK1161"],"gpt_icon":0},{"id":"2448510898","title":"国科恒泰(301370.SZ)拟与丹江口创瑞共设合资公司 经营医疗器械生产及技术咨询服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2448510898","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448510898?lang=zh_cn&edition=full","pubTime":"2024-07-03 18:34","pubTimestamp":1720002864,"startTime":"0","endTime":"0","summary":"智通财经APP讯,国科恒泰(301370.SZ)公告,公司拟与丹江口创瑞企业管理合伙企业(有限合伙)(简称“丹江口创瑞”)共同出资在天津市设立公司,主营业务为医疗器械的生产及技术咨询服务。注册资本为1000万元人民币,其中公司持股比例为60.00%;丹江口创瑞持股比例为40.00%。公司本次拟设立子公司系公司业务发展需要,有利于公司积极开拓和充分利用市场,增强公司的核心竞争力以及综合盈利能力,扩大市场占有率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145161.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","09996","BK1574","BK1100","BK1222","09997","301370","BK0250"],"gpt_icon":0},{"id":"2444168430","title":"国科恒泰:根据中登公司定期下发的股东名册显示,截至2024年6月7日,公司股东人数为16,674户","url":"https://stock-news.laohu8.com/highlight/detail?id=2444168430","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444168430?lang=zh_cn&edition=full","pubTime":"2024-06-17 19:00","pubTimestamp":1718622042,"startTime":"0","endTime":"0","summary":"证券之星消息,国科恒泰06月17日在投资者关系平台上答复投资者关心的问题。根据中登公司定期下发的股东名册显示,截至2024年6月7日,公司股东人数为16,674户,感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061700023181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2440468502","title":"国科恒泰:根据中登公司定期下发的股东名册显示,截至2024年5月31日,公司股东人数为17,011户","url":"https://stock-news.laohu8.com/highlight/detail?id=2440468502","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440468502?lang=zh_cn&edition=full","pubTime":"2024-06-03 18:01","pubTimestamp":1717408910,"startTime":"0","endTime":"0","summary":"证券之星消息,国科恒泰(301370)06月03日在投资者关系平台上答复投资者关心的问题。投资者:最新股东人数国科恒泰董秘:尊敬的投资者,您好!根据中登公司定期下发的股东名册显示,截至2024年5月31日,公司股东人数为17,011户,感谢您的关注。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300022985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301370"],"gpt_icon":0},{"id":"2437994254","title":"国科恒泰(301370)5月20日股东户数1.69万户,较上期减少0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437994254","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437994254?lang=zh_cn&edition=full","pubTime":"2024-05-21 17:04","pubTimestamp":1716282296,"startTime":"0","endTime":"0","summary":"证券之星消息,近日国科恒泰披露,截至2024年5月20日公司股东户数为1.69万户,较5月10日减少119.0户,减幅为0.7%。在医疗器械行业个股中,国科恒泰股东户数低于行业平均水平,截至5月20日,医疗器械行业平均股东户数为2.09万户。从股价来看,2024年5月10日至2024年5月20日,国科恒泰区间跌幅为2.68%,在此期间股东户数减少119.0户,减幅为0.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052100028667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370","BK0250"],"gpt_icon":0},{"id":"2430263482","title":"国科恒泰(301370)2024年一季报简析:净利润增4.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430263482","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430263482?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:32","pubTimestamp":1714084367,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期国科恒泰发布2024年一季报。根据财报显示,本报告期中国科恒泰净利润增4.82%。截至本报告期末,公司营业总收入17.14亿元,同比下降3.0%,归母净利润2760.55万元,同比上升4.82%。营收分析方面,公司最新一期年度报表的现金流为正,经营性现金流比利润高太多,通常是好事,建议确认原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600014106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370"],"gpt_icon":0},{"id":"2430461051","title":"图解国科恒泰一季报:第一季度单季净利润同比增4.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430461051","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430461051?lang=zh_cn&edition=full","pubTime":"2024-04-25 01:49","pubTimestamp":1713980956,"startTime":"0","endTime":"0","summary":"证券之星消息,国科恒泰2024年一季报显示,公司主营收入17.14亿元,同比下降3.0%;归母净利润2760.55万元,同比上升4.82%;扣非净利润2755.74万元,同比上升3.65%;负债率63.88%,财务费用1952.69万元,毛利率10.52%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500002506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370"],"gpt_icon":0},{"id":"2430695454","title":"图解国科恒泰年报:第四季度单季净利润同比增105.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430695454","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430695454?lang=zh_cn&edition=full","pubTime":"2024-04-25 00:50","pubTimestamp":1713977450,"startTime":"0","endTime":"0","summary":"证券之星消息,国科恒泰2023年年报显示,公司主营收入74.83亿元,同比上升17.66%;归母净利润1.54亿元,同比上升23.19%;扣非净利润1.49亿元,同比上升26.01%;其中2023年第四季度,公司单季度主营收入17.22亿元,同比上升17.39%;单季度归母净利润6287.12万元,同比上升105.79%;单季度扣非净利润6155.91万元,同比上升113.56%;负债率63.75%,投资收益-498.8万元,财务费用8715.03万元,毛利率11.75%。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500000815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370"],"gpt_icon":0},{"id":"2429203454","title":"国科恒泰最新公告:一季度净利润2760.55万元 同比增长4.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429203454","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429203454?lang=zh_cn&edition=full","pubTime":"2024-04-24 22:20","pubTimestamp":1713968454,"startTime":"0","endTime":"0","summary":"国科恒泰公布2024年一季度报告,报告期营业收入17.14亿元,同比下降3.00%;归属于上市公司股东的净利润2760.55万元,同比增长4.82%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400046749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301370"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2023-07-12","address":"北京市大兴区北京经济技术开发区经海四路25号6号楼5层501C室","stockEarnings":[{"period":"1week","weight":-0.0709},{"period":"1month","weight":-0.1746},{"period":"3month","weight":-0.2459},{"period":"6month","weight":-0.3069},{"period":"1year","weight":-0.4664},{"period":"ytd","weight":-0.4011}],"companyName":"国科恒泰(北京)医疗科技股份有限公司","boardCode":"AI0051","perCapita":"19825股","boardName":"批发业","registeredCapital":"47060万元","compareEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":-0.0176},{"period":"3month","weight":-0.0362},{"period":"6month","weight":0.0461},{"period":"1year","weight":-0.0735},{"period":"ytd","weight":-0.0041}],"survey":" 国科恒泰(北京)医疗科技股份有限公司的主营业务是从事医疗器械的分销和直销业务,并在业务开展过程中提供仓储物流配送、流通渠道管理、流通过程信息管理以及医院SPD运营管理等专业服务;公司的主要产品是冠脉介入治疗材料、外周血管介入、骨科材料、消化介入材料、神经外科材料、口腔材料、仓储物流配送服务、渠道管理服务、信息管理服务、医院 SPD 运营服务。","serverTime":1721316758140,"listedPrice":13.39,"stockholders":"16330人(较上一季度减少2.06%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国科恒泰(301370)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国科恒泰(301370)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国科恒泰,301370,国科恒泰股票,国科恒泰股票老虎,国科恒泰股票老虎国际,国科恒泰行情,国科恒泰股票行情,国科恒泰股价,国科恒泰股市,国科恒泰股票价格,国科恒泰股票交易,国科恒泰股票购买,国科恒泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国科恒泰(301370)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国科恒泰(301370)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}